Project Grant R43GH001236

Lo Biosciences, Inc., a minority-owned biotechnology company based in Rockville, Maryland, received a $1,989,316 Project Grant from the Centers for Disease Control and Prevention (CDC) Investigations and Technical Assistance program (CFDA 93.283) awarded on September 30, 2025. The award supports the development of a novel remote blood separation device designed to enable at-home plasma collection for human immunodeficiency virus (HIV-1) testing. The project will be completed by September 29,...

Advanced Virology Inc. received a $279,270 Project Grant from the Centers for Disease Control and Prevention (CDC) under the CDC Investigations and Technical Assistance program (CFDA 93.283) for the period September 30, 2025 through September 29, 2026. The award supports the development of low-cost and high-efficiency deoxyribonucleic acid (DNA)-based reverse genetics platforms designed for manufacturing ribonucleic acid (RNA) virus products. This initiative aligns with the CDC's broader mission...

This National Science Foundation (NSF) Small Business Innovation Research (SBIR) Phase I award to RT Microdx Inc. provides $274,362 to develop a novel molecular diagnostic platform for detecting respiratory diseases like strep throat. The platform aims to provide laboratory-quality accuracy for at-home use by non-healthcare professionals. Key technical objectives include optimizing the sensitivity of the platform's pH-sensitive polymer detection mechanism and ensuring robust performance at...

Aptus Biosciences LLC, a minority-owned small business based in Gainesville, Florida, received a $1,002,400 Project Grant award dated September 30, 2025, from the Centers for Disease Control and Prevention (CDC) under the Prevention of Disease, Disability, and Death by Infectious Diseases program (CFDA 93.084). The award supports the development of a rapid, affordable aptamer-based diagnostic test for Hepatitis C Virus (HCV). The project period extends through September 29, 2026, and leverages...

Federal Project Grant Award Summary Pace Diagnostics, Inc. received a $600,000 Project Grant from the Centers for Disease Control and Prevention (CDC) under the CDC Investigations and Technical Assistance program (CFDA 93.283), awarded on September 30, 2025, with a completion date of March 31, 2026. The award supports the development of an ultrasensitive urine-based tuberculosis (TB) antigen rapid detection test for diagnosing active tuberculosis. This diagnostic tool represents the program's...

Partillion Bioscience Corp. was awarded a $659,037 Project Grant from the National Institutes of Health's National Institute of General Medical Sciences to develop reagent products enabling high-throughput screening and selection of single cells based on secreted bio-products. Under the Biomedical Research and Research Training program (CFDA 93.859), Partillion plans to transition its lab-on-a-particle technology—highlighted as a 2020 SLAS Innovation Award winner—into the first reagent product...

Grant Award Summary The National Institute of Allergy and Infectious Diseases (NIAID) awarded $451,000 to The Regents of the University of California, San Francisco under the Allergy and Infectious Diseases Research program (CFDA 93.855) on April 1, 2026, for a two-year project concluding March 31, 2028. The grant funds development of the Digital Droplet Aerosol Capture & Quantification (DDACQ) system, a portable technology platform designed to enable rapid detection and quantitative...

Case Western Reserve University, Office of Research Administration, received a $816,379 Project Grant award from the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855), effective May 21, 2026 through April 30, 2031. The award funds development of HIV-CRISP, a point-of-care diagnostic platform designed to address critical gaps in HIV drug resistance testing accessibility and turnaround time in the United States....

This $788,406 project grant from the National Institutes of Health National Institute of Allergy and Infectious Diseases, under the Allergy and Infectious Diseases Research program (CFDA 93.855), will fund the development of a sensitive, direct reading bioaerosol detection platform to quantify airborne pathogens such as SARS-CoV-2. Aerosol Devices Inc. will integrate their gentle condensation-growth capture sampler, which concentrates intact, viable virus particles into a small liquid volume...

The Department of Defense, through the Military Medical Research and Development program (CFDA 12.420), awarded a $1,857,470 Cooperative Agreement to The Geneva Foundation to develop a multiplex testing platform that can simultaneously detect and identify Plasmodium species infections. This platform will serve as both a diagnostic tool and an epidemiological surveillance tool. The project performance period is from June 1, 2024 to May 31, 2028. Under a $268,312 sub-award, Meso Scale...